{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:13:17Z","timestamp":1755216797283,"version":"3.43.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:p>Gliosarcoma is rare among pediatric patients and among individuals with Neurofibromatosis Type 1 (NF1). Here we compare 2 pediatric gliosarcoma patients, one of whom has NF1. We performed whole-exome sequencing, methylation, and copy number analysis on tumor and blood for both patients. Whole-exome sequencing showed higher mutational burden in the tumor of the patient without NF1. Copy number analysis showed differences in chromosomal losses\/gains between the tumors. Neither tumor showed O6-methylguanine-DNA methyltransferase (<jats:italic toggle=\"yes\">MGMT<\/jats:italic>) promoter methylation. The NF1 patient survived without progression while the other expired. This is the first reported case of gliosarcoma in a child with NF1.<\/jats:p>","DOI":"10.1097\/mph.0000000000002020","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T19:04:50Z","timestamp":1606244690000},"page":"e1201-e1204","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric Gliosarcoma With and Without Neurofibromatosis Type 1: A Whole-exome Comparison of 2 Patients"],"prefix":"10.1097","volume":"43","author":[{"given":"Richard T.","family":"Graham","sequence":"first","affiliation":[{"name":"Division of Neuro-Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica H.","family":"Bell","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Webb","sequence":"additional","affiliation":[{"name":"Center for Biostatistics, The Ohio State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[{"name":"Center for Biostatistics, The Ohio State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Timmers","sequence":"additional","affiliation":[{"name":"The Ohio State University Comprehensive Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Fleming","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blake E.","family":"Sells","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan J.","family":"Robison","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Children\u2019s Hospital Los Angeles, Los Angeles, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Palmer","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Finlay","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology\/BMT, Nationwide Children\u2019s Hospital, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnab","family":"Chakravarti","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11060-009-0021-3","article-title":"Clinical and epidemiological characteristics of pediatric gliosarcomas","volume":"97","author":"Karremann","year":"2010","journal-title":"J Neurooncol"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/now207","article-title":"CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013","volume":"18","author":"Ostrom","year":"2016","journal-title":"Neuro Oncol"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1007\/s00381-015-2919-8","article-title":"Pediatric gliosarcoma treated with adjuvant radiotherapy and temozolomide","volume":"31","author":"Mallick","year":"2015","journal-title":"Childs Nerv Syst"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00381-009-1024-2","article-title":"Neurofibromatosis type 1 and high-grade tumors of the central nervous system","volume":"26","author":"Rosenfeld","year":"2010","journal-title":"Childs Nerv Syst"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/030089160108700114","article-title":"Gliosarcoma associated with neurofibromatosis type I: a case report","volume":"87","author":"Elmaci","year":"2001","journal-title":"Tumori"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/gcc.2870030111","article-title":"Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis","volume":"3","author":"Glover","year":"1991","journal-title":"Genes Chromosomes Cancer"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00415-014-7292-0","article-title":"Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab","volume":"261","author":"Theeler","year":"2014","journal-title":"J Neurol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.clineuro.2010.04.012","article-title":"Transformation of intracranial anaplastic astrocytoma associated with neurofibromatosis type I into gliosarcoma: case report","volume":"112","author":"Cheong","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/pbc.22462","article-title":"Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1","volume":"54","author":"Huttner","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9440(10)64746-3","article-title":"Genetic profile of gliosarcomas","volume":"156","author":"Reis","year":"2000","journal-title":"Am J Pathol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/gcc.10087","article-title":"Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components","volume":"34","author":"Actor","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"iii39","DOI":"10.1093\/neuonc\/nov061.159","article-title":"TR-14: a feasibility and randomized phase II study of vorinostat, bevacizumab, or temozolomide during radiation followed by maintenance chemotherapy in newly-diagnosed pediatric high-grade glioma: children\u2019s oncology group study ACNS0822","volume":"17","author":"Hoffman","year":"2015","journal-title":"Neuro-Oncology"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1212\/WNL.0000000000008623","article-title":"NF1 glioblastoma clonal profiling reveals KMT2B mutations as potential somatic oncogenic events","volume":"93","author":"Wong","year":"2019","journal-title":"Neurology"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41591-018-0263-8","article-title":"The molecular landscape of glioma in patients with neurofibromatosis 1","volume":"25","author":"D\u2019Angelo","year":"2019","journal-title":"Nat Med"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/cancers11030284","article-title":"Gliosarcoma is driven by alterations in PI3K\/Akt, RAS\/MAPK pathways and characterized by collagen gene expression signature","volume":"11","author":"Wojtas","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1158\/0008-5472.CAN-14-2378","article-title":"Accuracy of molecular data generated with FFPE biospecimens: lessons from the literature","volume":"75","author":"Greytak","year":"2015","journal-title":"Cancer Res"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T21:00:18Z","timestamp":1754341218000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002020","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"assertion":[{"value":"2020-08-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}